15-min delayed · Sep 8, 3:15 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for XRTX yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $2.20 current
Highest Target—
Average Target—
Lowest Target—
XRTX EPS & revenue forecast
EPS · THIS QUARTER
$-0.32
Range $-0.32 – $-0.32 · 1 analysts · -61% YoY
Next period, 1 analysts expect XORTX Therapeutics Inc to earn $-0.32 a share (range $-0.32 – $-0.32), versus $-0.81 a year earlier. , growing to $1.10 the year after.
REVENUE · THIS QUARTER
—
Range — – — · 1 analysts
Revenue is expected to reach — (range — – —). Full-year consensus is $0, rising to $22.0M next year.
XRTX stock forecast FAQ
What is XORTX Therapeutics Inc's projected EPS for next quarter?+
The consensus estimate is $-0.32 per share (range $-0.32 – $-0.32) across 1 analysts. Full-year EPS is projected at —, rising to $1.10 the following year.
How much revenue is XORTX Therapeutics Inc expected to report next quarter?+
Consensus revenue is — (range — – —). Full-year revenue is projected at $0, growing to $22.0M next year.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XRTX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
